All Journals

Advances scholarship across the full spectrum of cardiology and cardiovascular medicine, from molecular mechanisms of atherosclerosis to evidence that shapes bedside practice. JOCD welcomes original research, systematic reviews and meta-analyses, clinical case reports, and editorials spanning heart failure, coronary artery disease, myocardial infarction, arrhythmia and electrophysiology, interventional and surgical cardiology, preventive cardiology, lipid disorders, and cardiac rehabilitation. We encourage translational work connecting biomechanics, imaging, pharmacotherapy, and exercise therapy to measurable patient outcomes. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each article receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and exposed via an OAI-PMH endpoint for harvesting. The journal follows COPE ethical principles and applies an article-processing charge on acceptance, with waivers and discounts available to ensure equitable access for all authors.

Devoted to the science and clinical practice of respiratory medicine and pulmonology. As a respiratory medicine journal serving an international community of pulmonologists, intensivists, microbiologists, and respiratory scientists, JRMR disseminates rigorous original work spanning the diagnosis, mechanisms, and management of lung disease. The journal welcomes original research, reviews, clinical trials, and case reports across chronic obstructive pulmonary disease (COPD), asthma, pulmonary tuberculosis and respiratory infections, interstitial and occupational lung disease (including silicosis and pneumoconioses), acute respiratory failure, mechanical ventilation and weaning, ventilator-associated pneumonia, and critical-care pulmonology. Methodological contributions in molecular diagnostics (PCR, Xpert MTB/RIF), pulmonary immunology, innate immunity, and respiratory pathophysiology are particularly encouraged. Every submission undergoes double-blind peer review in line with COPE ethical principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, allowing authors to retain copyright, and each receives a permanent Crossref DOI. Content is discoverable through Google Scholar and OpenAlex and harvestable via the journal's OAI-PMH endpoint, supporting wide citation and long-term preservation of the respiratory research record.

Dedicated to the science and clinical management of high blood pressure. It connects cardiologists, nephrologists, internists, vascular medicine specialists, pharmacologists, and public-health researchers across the full spectrum of hypertension. We publish original research, reviews, clinical trials, case reports, and editorials on essential and secondary hypertension, antihypertensive pharmacotherapy, single-pill combination regimens (e.g., amlodipine-losartan, chlorthalidone), cardiovascular risk stratification, ambulatory and home blood pressure monitoring, resistant hypertension, and hypertension in special populations. Epidemiological and public-health studies on blood pressure control and quality of life are equally welcome. Every submission undergoes double-blind peer review. Accepted articles appear open access under a Creative Commons Attribution (CC-BY 4.0) licence, authors retain copyright, and each receives a permanent Crossref DOI for discoverability via OpenAlex, Google Scholar, and our OAI-PMH endpoint.

Dedicated to the science and clinical practice of vascular medicine. It publishes original research, systematic and narrative reviews, clinical trials, case reports and editorials spanning the full arterial, venous and lymphatic spectrum, connecting vascular physicians, angiologists, hematologists, cardiologists, vascular surgeons and translational scientists worldwide. Core topics include peripheral artery disease, critical limb ischemia, carotid and aortic disease, venous thromboembolism, deep vein thrombosis, pulmonary embolism and chronic venous insufficiency. We also welcome work on vascular biology and endothelial dysfunction, atherosclerosis, angiogenesis, thrombosis and hemostasis, anticoagulation management, vascular imaging, and endovascular and medical therapy. Emerging and special-population themes are encouraged, including fibromuscular dysplasia, spontaneous coronary artery dissection, onco-vascular medicine and diabetic vascular disease, bridging bench mechanisms to bedside outcomes. Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons CC-BY 4.0 licence with authors retaining copyright, receive a permanent Crossref DOI, and are made discoverable through OpenAlex, Google Scholar and an OAI-PMH endpoint, following COPE ethical principles.